Using a genome-wide CRISPR dropout screen, we identified genetic vulnerabilities, many involved in mitochondrial metabolism, including several genes (for example, SLC25A1, LDLR and HK3) whose expression correlates with worse AML patient survival. The gene discussed is HK3; the disease is acute myeloid leukemia.